Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Feb 2, 2016

American Diabetes Association Announces Research Grant Award Recipients

Six researchers each receive $1.625 million in "Pathway to Stop Diabetes®" awards
Jan 8, 2016

Sanofi and Regeneron Announce Sarilumab Biologics License Application Accepted for Review by US FDA
Dec 23, 2015

Sanofi Submits New Drug Application for the Once-Daily Fixed-Ratio Combination of Insulin Glargine and Lixisenatide
Dec 1, 2015

Sanofi Launches New Priftin® (Rifapentine) Packaging

New 24 and 32-Packs Designed to Manage Dosage Regimens for both Latent and Active Tuberculosis
- Photos 1
Nov 20, 2015

Perceptions of Counterfeit Medicines: Only 12% of Americans Feel They Have Enough Information

- A study conducted with 1,500 Americans in July 2015 examined perceived risks of counterfeit medicines[1] -
Nov 6, 2015

Sanofi and Lexicon Pharmaceuticals To Collaborate on Sotagliflozin, an Investigational New Oral Medicine for People with Diabetes
Nov 5, 2015

Sanofi and Hanmi Announce License Agreement To Develop Portfolio of Long-Acting Diabetes Treatments
Oct 30, 2015

UPDATED: Sanofi US Issues Voluntary Nationwide Recall of All Auvi-Q® Due to Potential Inaccurate Dosage Delivery
- Photos 1
Oct 29, 2015

Sanofi Grew Sales and Business EPS in Q3 2015
- Photos 1
Sep 29, 2015

Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA

- First New Drug Application for a GLP-1 receptor agonist to include CV outcomes data -

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.